NFKB1 and familial pancreatic carcinoma: Here, for the first time, we found that emodin inhibited the angiogenesis of pancreatic cancer in vivo, downregulated the expression of NF-κB and NF-κB-regulated proteins with roles in angiogenesis inhibition (VEGF, MMP-2, MMP-9, and eNOS).